Protein detail

FGFR1

Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)

Entry name
FGFR1
UniProt ID
EVMP confidence score
0.25
Supporting publications (n)
1
Transmembrane count
1
Protein classification
Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)
Protein Class (11)
Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteinsTransporters
Protein Function (14)
  • Predicted intracellular proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
  • ENZYME proteins:Transferases
  • Human disease related genes:Cancers:Cancers of the breast and female genital organs
  • Human disease related genes:Endocrine and metabolic diseases:Hypothalamus and pituitary gland diseases
  • CD markers
  • RAS pathway related proteins
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
  • Transporters:Accessory Factors Involved in Transport
Page 1 of 2
Transmembrane
377..397; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (11)
BFGFRCD331CEKFLGFLT2H2H3H4H5KAL2N-SAM
Gene Description
Fibroblast growth factor receptor 1
Chromosome
8
Position
38400215-38468834
Supporting publications (n)
1
EVMP confidence score
0.25
Fluorescence & Localization1
FGFR1 fluorescence
Function & Pathway6
Protein Function (14)
  • Predicted intracellular proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
  • ENZYME proteins:Transferases
  • Human disease related genes:Cancers:Cancers of the breast and female genital organs
  • Human disease related genes:Endocrine and metabolic diseases:Hypothalamus and pituitary gland diseases
  • CD markers
  • RAS pathway related proteins
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
  • Transporters:Accessory Factors Involved in Transport
Page 1 of 2
Mediation Categories (5)
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence127

Enzyme-Mediated Modification (23)

23 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
FGFR1PRKCEQ02156S779phosphorylationSIGNORProtMapperSIGNOR_ProtMapperPhosphoSitePhosphoSite_ProtMapperSIGNOR:23564461ProtMapper:23564461
FGFR1PRKCEQ02156S810phosphorylationMIMPPhosphoSite_MIMP
FGFR1MAPK14Q16539S777phosphorylationSparser_ProtMapperSIGNORProtMapperRLIMS-P_ProtMapperKEASIGNOR_ProtMapperPhosphoSitePhosphoSite_ProtMapperKEA:18411303ProtMapper:20626350ProtMapper:18411303SIGNOR:20626350
FGFR1MAPK14Q16539S808phosphorylationMIMPPhosphoSite_MIMP
FGFR1MAPK3P27361S777phosphorylationSparser_ProtMapperSIGNORProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper:27342992ProtMapper:23405013SIGNOR:23405013
FGFR1MAPK3P27361S808phosphorylationMIMPPhosphoSite_MIMP
FGFR1MAPK1P28482S777phosphorylationSparser_ProtMapperSIGNORProtMapperRLIMS-P_ProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper:27342992ProtMapper:23405013SIGNOR:23405013
FGFR1MAPK1P28482S808phosphorylationMIMPPhosphoSite_MIMP
FGFR1MMP2P08253V366cleavageHPRDHPRD:8692946
FGFR1MMP2P08253V279cleavageHPRDHPRD:8692946
Page 1 of 3Next

Ligand-Receptor Signaling (68)

68 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
extracellularextracellularHPMRNoNoNoYesNo
extracellularextracellularOmniPathNoNoNoYesNo
intracellularintracellularLOCATENoNoNoYesNo
intracellularintracellularComPPINoNoNoYesNo
intracellularintracellularGO_IntercellNoNoNoYesNo
intracellularintracellularUniProt_locationNoNoNoYesNo
intracellularintracellularOmniPathNoNoNoYesNo
cell_adhesioncell_adhesionCellinkerYesYesNoYesNo
matrix_adhesionmatrix_adhesionCellinkerNoYesNoYesNo
adhesionadhesionOmniPathYesYesNoYesNo
Page 3 of 7PreviousNext

Regulatory Interaction Network (23)

23 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
FGF1P05230FGFR1P11362YesYesNoiTALKICELLNETSIGNORProtMapperHINTSignaLink3DIPLit-BM-17HPMR_talklrHPMRCellChatDBHPRD_LRdbDLRP_CellinkertalklrHPRDIntActDLRP_talklrRamilowski2015_Baccin2019WangRamilowski2015HPMR_LRdbCellPhoneDBHPRD_talklrBioGRIDBaccin2019CellinkerSTRING_talklrEMBRACECellCallCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020Reactome_ProtMapperSPIKE_LCLRdbHINT:11714710Cellinker:25772309BioGRID:8756477HPRD:11032250Lit-BM-17:11714710HINT:10748122HINT:1697263BioGRID:9624181HPMR:8663044IntAct:18441324HINT:1309595SignaLink3:11030354Cellinker:10336501Lit-BM-17:7730326DIP:1722683HINT:1709094Baccin2019:8756477HINT:9624181HINT:22955284HINT:11030354IntAct:25241761SignaLink3:8576175Lit-BM-17:10830168connectomeDB2020:11032250connectomeDB2020:8756477ICELLNET:25772309Lit-BM-17:23597563Lit-BM-17:11030354DIP:7730326BioGRID:1309595BioGRID:1383494CellTalkDB:16597617HINT:1383494SIGNOR:11030354IntAct:14613973connectomeDB2020:10336501HINT:10830168HINT:18261743IntAct:10830168DIP:22244757HINT:22244757HINT:8576175Lit-BM-17:8576175HINT:8756477HINT:22057274SignaLink3:23331499HPRD:10336501Cellinker:8663044HINT:33961781SignaLink3:21071413Lit-BM-17:1722683Baccin2019:8663044Baccin2019:11032250Lit-BM-17:18441324Lit-BM-17:25241761Baccin2019:10336501HINT:28769084HINT:8321198Cellinker:11032250DIP:10830168HINT:18441324Cellinker:8756477SIGNOR:18940940Cellinker:16597617HINT:14613973LRdb:16597617HINT:8692946SPIKE_LC:16189514connectomeDB2020:8663044
FGFR1P11362FRS2Q8WU20YesYesYesWangSparser_ProtMapperPhosphoPointSIGNORProtMapperHPRDHINTPhosphoSite_KEAKEABioGRIDACSNSignaLink3SPIKE_LCLit-BM-17ACSN:15574420SignaLink3:9660748ACSN:16488589HPRD:11877385ACSN:11274345Lit-BM-17:11877385ACSN:17496910ACSN:15567848ProtMapper:25394172HINT:11877385HINT:21765395Lit-BM-17:11090629ACSN:14585353ACSN:12040186SIGNOR:9182757HINT:11090629ACSN:11777939ACSN:11447289HINT:10464310Lit-BM-17:10629055KEA:9632781ACSN:15173823HPRD:9632781SignaLink3:23331499Lit-BM-17:9660748BioGRID:10629055BioGRID:11877385ACSN:19568798HPRD:11090629ACSN:6321473HINT:9660748ACSN:11997436Lit-BM-17:21765395SPIKE_LC:16189514
FGFR1P11362GRB14Q14449YesYesNoPhosphoPointHPRDHINTSignaLink3Lit-BM-17HINT:20932831HPRD:10713090SignaLink3:10713090HINT:10713090SignaLink3:23331499Lit-BM-17:10713090
FGFR1P11362SHBQ15464YesYesNoPhosphoPointSignaLink3SignaLink3:7537362SignaLink3:23331499
FGFR1P11362PDP1Q9P0J1YesNoYesSparser_ProtMapperPhosphoSite_norefSIGNORiPTMnetProtMapperPhosphoSitePhosphoSite_ProtMapperSIGNOR:24962578PhosphoSite:24962578ProtMapper:24486017
FGFR1P11362PDK1Q15118YesYesNoPhosphoSite_MIMPMIMPPhosphoSite_norefSIGNORiPTMnetProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper:22195962PhosphoSite:22195962SIGNOR:22195962
MK01P28482FGFR1P11362YesNoYesWangSparser_ProtMapperPhosphoSite_MIMPMIMPiPTMnetSIGNORProtMapperRLIMS-P_ProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSite_ProtMapperProtMapper:27342992ProtMapper:23405013SIGNOR:23405013
FGFR1P11362HNRPQO60506YesNoYesphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointSIGNORProtMapperPhosphoSite_KEAKEAphosphoELM_KEAphosphoELMSIGNOR_ProtMapperProtMapper:12601080SIGNOR:12601080phosphoELM:12601080KEA:12601080
FGFR1P11362BCAR1P56945YesYesNoWangPhosphoNetworksphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperPhosphoSite_KEAKEAphosphoELM_KEAphosphoELMLi2012SIGNOR_ProtMapperProtMapper:11019781SIGNOR:11019781phosphoELM:12601080SIGNOR:12601080ProtMapper:12601080KEA:12601080
FGFR1P11362PDPK1O15530YesYesNoSIGNORSIGNOR:22195962
Page 1 of 3Next

Protein Complex Composition (12)

12 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
FGF21-FGFR1c-KLB complexFGF21FGFR1KLBP11362Q86Z14Q9NSA10:0:0CORUMCORUM:68282224828817452648
FGFR1c-KLB complexFGFR1KLBP11362Q86Z140:0CORUMCORUM:683617452648
Klotho_FGFR1FGFR1KLP11362Q9UEF71:1CellPhoneDBCellPhoneDB:Klotho_FGFR1
CBX5CDR2CDT1CENPEDYNLL1FGFR1OP2GMNNNXF1POGZRPUSD2SLMAPTLK2UBQLN1ZMYM3O75496P45973P63167Q01850Q02224Q14202Q14BN4Q7Z3K3Q86UE8Q8IZ73Q9H211Q9NVK5Q9UBU9Q9UMX01:1:1:1:1:1:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC8832
CDR2CDT1CENPEDYNLL1FGFR1OP2GMNNNXF1POGZRPUSD2SLMAPTLK2UBQLN1ZMYM4O75496P63167Q01850Q02224Q14BN4Q5VZL5Q7Z3K3Q86UE8Q8IZ73Q9H211Q9NVK5Q9UBU9Q9UMX01:1:1:1:1:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC7347
FGF1FGFR1P05230P113622:2PDBPDB:3ojvPDB:1evt
FGF2FGFR1P09038P113622:2PDBPDB:1cvsPDB:1fq9
FGFR1P113622PDBPDB:3js2PDB:7ozdPDB:4f65PDB:4f64PDB:4uwcPDB:5b7vPDB:4rwlPDB:4v04PDB:4rwiPDB:6mzwPDB:5am7PDB:6c1cPDB:6c1oPDB:6c18PDB:6nvlPDB:9cd5PDB:8xz7PDB:4nkaPDB:4rwjPDB:6c1bPDB:4wunPDB:4nk9PDB:1agwPDB:5ew8PDB:4rwkPDB:5ur1PDB:5vndPDB:2fgiPDB:5uq0PDB:3gqlPDB:6p69PDB:8y22PDB:6mzqPDB:1fgkPDB:5flfPDB:8jmzPDB:3ky2PDB:3kxxPDB:6c19PDB:5z0sPDB:7ozbPDB:6itjPDB:4uwyPDB:4nksPDB:4uwbPDB:8xloPDB:3c4fPDB:6p68PDB:1fgiPDB:8ykiPDB:4v05PDB:4f63PDB:5o49PDB:5a4cPDB:4v01PDB:7wclPDB:3rhxPDB:5am6PDB:5zv2PDB:7ozfPDB:5o4aPDB:5a46PDB:4zsaPDB:3tt0
FGFR1PLCG2P11362P168851:1PDBPDB:8jqi
FGF9FGFR1P11362P313711:1PDBPDB:5w59
Page 1 of 2Next

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry127863537
Sequence, Structure & Domains15

Sequences

Length
822
Mass
91,868
Sequence
MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR
Alternative Products
Event=Alternative splicing; Named isoforms=21; Name=1; Synonyms=Alpha A1, IV; IsoId=P11362-1; Sequence=Displayed; Name=2; Synonyms=Alpha A2; IsoId=P11362-8; Sequence=VSP_009842, VSP_009843; Name=3; Synonyms=Alpha A3; IsoId=P11362-17; Sequence=VSP_009836, VSP_009837; Name=4; Synonyms=Alpha B1; IsoId=P11362-2; Sequence=VSP_002960; Name=5; Synonyms=Alpha B2; IsoId=P11362-9; Sequence=VSP_002960, VSP_009842, VSP_009843; Name=6; Synonyms=Beta A1, II, H2; IsoId=P11362-3; Sequence=VSP_002958; Name=7; Synonyms=Beta A2; IsoId=P11362-10; Sequence=VSP_002958, VSP_009842, VSP_009843; Name=8; Synonyms=Beta B1; IsoId=P11362-4; Sequence=VSP_002958, VSP_002960; Name=9; Synonyms=Beta B2; IsoId=P11362-11; Sequence=VSP_002958, VSP_002960, VSP_009842, VSP_009843; Name=10; Synonyms=Gamma A1; IsoId=P11362-5; Sequence=VSP_002957; Name=11; Synonyms=Gamma A2; IsoId=P11362-12; Sequence=VSP_002957, VSP_009842, VSP_009843; Name=12; Synonyms=Gamma B1; IsoId=P11362-6; Sequence=VSP_002957, VSP_002960; Name=13; Synonyms=Gamma B2; IsoId=P11362-13; Sequence=VSP_002957, VSP_002960, VSP_009842, VSP_009843; Name=14; Synonyms=A, III; IsoId=P11362-7; Sequence=VSP_002959; Name=15; Synonyms=I, H3; IsoId=P11362-14; Sequence=VSP_002958, VSP_002959; Name=16; Synonyms=V; IsoId=P11362-15; Sequence=VSP_009838, VSP_009839; Name=17; Synonyms=H4; IsoId=P11362-16; Sequence=VSP_002958, VSP_009840, VSP_009841; Name=18; Synonyms=H5; IsoId=P11362-18; Sequence=VSP_002958, VSP_002959, VSP_009840, VSP_009841; Name=19; IsoId=P11362-19; Sequence=VSP_038470, VSP_002959, VSP_038471; Name=20; IsoId=P11362-20; Sequence=VSP_041916, VSP_041918; Name=21; IsoId=P11362-21; Sequence=VSP_041917, VSP_002959
Alternative Sequence
1..160; Missing (in isoform 10, isoform 11, isoform 12 and isoform 13); 1..30; MWSWKCLLFWAVLVTATLCTARPSPTLPEQ -> MAAVTRDFGEMLLHSGRVLPAE (in isoform 20); 1; M -> MEARVSLKRRIELTVEYPWRCGALSPTSNCRTGM (in isoform 21); 31..119; Missing (in isoform 6, isoform 7, isoform 8, isoform 9, isoform 15, isoform 17 and isoform 18); 32..61; QPWGAPVEVESFLVHPGDLLQLRCRLRDDV -> CPDLQEAKSCSASFHSITPLPFGLGTRLSD (in isoform 3); 62..822; Missing (in isoform 3); 119; S -> SVPI (in isoform 19); 120..150; DALPSSEDDDDDDDSSSEEKETDNTKPNRMP -> ACPDLQEAKWCSASFHSITPLPFGLGTRLSD (in isoform 16); 148..149; Missing (in isoform 14, isoform 15, isoform 18, isoform 19 and isoform 21); 151..822; Missing (in isoform 16); 313..391; TAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMV -> VIMAPVFVGQSTGKETTVSGAQVPVGRLSCPRMGSFLTLQAHTLHLSRDLATSPRTSNRGHKVEVSWEQRAAGMGGAGL (in isoform 17 and isoform 18); 313..360; TAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLE -> HSGINSSDAEVLTLFNVTEAQSGEYVCKVSNYIGEANQSAWLTVTRP (in isoform 19); 392..822; Missing (in isoform 17 and isoform 18); 427..428; Missing (in isoform 20); 428..429; Missing (in isoform 4, isoform 5, isoform 8, isoform 9, isoform 12 and isoform 13); 619..662; CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL -> VWNLKAPLVHTPRPGSQECPGDRGQCDEDSRLWPRTGHSPHRLL (in isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13); 663..822; Missing (in isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13)

3D Structural Models

Turn
93..95; 210..213; 461..463; 469..471
Helix
159..161; 199..201; 222..224; 320..323; 475..477; 522..538; 569..574; 591..593; 597..616; 626..628; 648..650; 663..666; 669..674; 679..694; 706..714; 727..736; 741..743; 747..760
Beta Strand
40..42; 51..54; 63..72; 77..81; 83..88; 97..105; 108..116; 151..156; 165..169; 174..177; 180..184; 187..192; 207..209; 214..217; 226..234; 237..248; 265..268; 269..271; 273..276; 286..293; 296..300; 302..304; 307..313; 316..318; 325..328; 333..335; 337..345; 348..359; 478..486; 488..499; 501..503; 508..516; 547..551; 553..555; 558..562; 579..583; 584..586; 629..631; 637..639; 641..643; 653..655; 658..660; 676..678; 722..724
3D Structure
Electron microscopy (2); NMR spectroscopy (2); X-ray crystallography (75)

Domain & Motif Annotations

Compositional Bias
125..135; Acidic residues; 136..145; Basic and acidic residues; 778..792; Polar residues
Domain (CC)
The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans. Isoforms lacking the first Ig-like domain have higher affinity for fibroblast growth factors (FGF) and heparan sulfate proteoglycans than isoforms with all three Ig-like domains.
Domain (FT)
25..119; Ig-like C2-type 1; 158..246; Ig-like C2-type 2; 255..357; Ig-like C2-type 3; 478..767; Protein kinase
Region
120..154; Disordered; 160..177; Heparin-binding; 778..822; Disordered
Protein Families (3)
  • Protein kinase superfamily
  • Tyr protein kinase family
  • Fibroblast growth factor receptor subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily.
Clinical Relevance9
Disease Involvement (9)
Cancer-related genesCraniosynostosisDisease variantDwarfismFDA approved drug targetsHoloprosencephalyHypogonadotropic hypogonadismIntellectual disabilityKallmann syndrome
Biomarker
Phase 3; Phase 1; Phase 1/2; Phase 2; Investigative; Approved; Terminated
Drug Targets
FDA approved drug targets
Drugs (107)
AVUTOMETINIBPD-0166285LUCITANIBNINTEDANIB ESYLATEINFIGRATINIBNULLMUPARFOSTATALPELISIBOLVEREMBATINIBGW843682XXL999TOZASERTIBARSENIC TRIOXIDEGW441756XBRIVANIBFEXAGRATINIBTG100-801XL228ZOTATIFINMIDOSTAURINDERAZANTINIBPAZOPANIBGUNAGRATINIBMK-2461PD173074PALIFERMINDEHYDRATED ALCOHOLRG-1530VANDETANIBAST-487GO-6976DOCETAXEL ANHYDROUSCARBOPLATINHMPL-453ALISERTIBFGFR INHIBITOR CPL304110PONATINIBALSTERPAULLONEMASITINIBRABEPRAZOLECHEMBL:CHEMBL578061ZOLIGRATINIBFP-1039PEMIGATINIBTRAMETINIB DIMETHYL SULFOXIDECP-547632MLN-8054AFIMOXIFENELENVATINIBODM-203CISPLATINREGORAFENIBPICTILISIBERDAFITINIBENMD-981693VARGATEFTASURGRATINIBROGARATINIBAZD8055SORAFENIBBUPARLISIBAZD-4547ENMD-2076BRIGATINIBCENISERTIBFUTIBATINIBCHEMBL:CHEMBL546797DOVITINIBNVP-TAE684SP-600125ROMIPLOSTIMLORLATINIBSULFATINIBLY-2874455ENTRECTINIBHESPERADINFGFR/CSF-1R INHIBITOR 3D185VISTUSERTIBPACLITAXELTAMATINIBILORASERTIBFINASTERIDECHEMBL:CHEMBL459729TOPICAL POTASSIUM DOBESILATEMEK INHIBITOR RO4987655PRN1371ORANTINIBCP-459632FGFR INHIBITOR DEBIO 1347TRAFERMINDASATINIB ANHYDROUSSELUMETINIBETOPOSIDEXL-999CEDIRANIBFGF-1SUNITINIBFGF RECEPTOR ANTAGONIST HGS1036PHA-665752SIROLIMUSJNJ-7706621BRIVANIB ALANINATEVACCINEINFIGRATINIB PHOSPHATECYC-116PF-562271KW-2449
Interaction Protein (12)
ENSG00000011201ENSG00000039068ENSG00000066468ENSG00000069869ENSG00000096384ENSG00000113578ENSG00000118972ENSG00000124181ENSG00000138685ENSG00000160867ENSG00000168036ENSG00000178394
Interaction Count
12
Interaction Dataset
intact_biogrid
Supporting Publications1
PMIDTitleAbstract
30646616Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.THBS1, ANXA6, HIST1H4A, COL18A1, MDK, SRGN, ENO1, TUBA4A, SLC3A2, GPI, MIF, MUC1, TALDO1, SLC7A5, ICAM1, HSP90AA1, G6PD, and LRP1 were found to be expressed in exosomes at more than 5-fold higher level as compared to total cellular membrane proteins.